About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline

LOG IN
LOG IN


H. Rept. 115-192,Part 1 1 (2017-06-23)

handle is hein.congrecreports/crptxaiod0001 and id is 1 raw text is: AUTHENTICATED r U.S. GOVERNMENT INFORMATION 4 115TH CONGRESS REPT.115-192 1st Session J HOUSE OF REPRESENTATIVES Part 1 MEDICAL CONTROLLED SUBSTANCES TRANSPORTATION ACT OF 2017 JUNE 23, 2017.-Committed to the Committee of the Whole House on the State of the Union and ordered to be printed Mr. WALDEN, from the Committee on Energy and Commerce, submitted the following REPORT [To accompany H.R. 1492] The Committee on Energy and Commerce, to whom was referred the bill (H.R. 1492) to amend the Controlled Substances Act to di- rect the Attorney General to register practitioners to transport con- trolled substances to States in which the practitioner is not reg- istered under the Act for the purpose of administering the sub- stances (under applicable State law) at locations other than prin- cipal places of business or professional practice, having considered the same, report favorably thereon without amendment and rec- ommend that the bill do pass. CONTENTS Page Purpose and Sum m ary ........................................................................................... . 2 Background and Need for Legislation .................................................................... 2 C om m ittee A ction ................................................................................................... . 2 C om m ittee V otes ..................................................................................................... 2 Oversight Findings and Recommendations ........................................................... 2 New Budget Authority, Entitlement Authority, and Tax Expenditures ............. 2 Congressional Budget Office Estimate ................................................................... 2 Federal M andates Statem ent ................................................................................. 3 Statement of General Performance Goals and Objectives ................. 3 Duplication of Federal Program s ............................................................................ 3 Com m ittee Cost Estim ate ....................................................................................... 3 Earmark, Limited Tax Benefits, and Limited Tariff Benefits .............. 3 Disclosure of Directed Rule M akings ..................................................................... 3 Advisory Com m ittee Statem ent .............................................................................. 3 Applicability to Legislative Branch ........................................................................ 3 Section-by-Section Analysis of the Legislation ...................................................... 3 Changes in Existing Law Made by the Bill, as Reported ................. 4 69-006